Our latest thinking, insights and company news

Request more information about RJW&partners

RJW&partners will only use your personal information to administer your account and provide the products and services you request. You can unsubscribe at any time, to do so please review our Privacy Policy. By clicking subscribe, you consent to allow RJW&partners to store and process your personal information.

Early Access Programmes in Europe Versus Key Markets in Other Regions: An In-Depth Comparison

Dec 10, 20244 min read

One step forward, two steps back: Is the UK driving away pharmaceutical manufacturers?

The UK voluntary scheme payback rate on NHS sales of branded medicines was set to 26.5%. Is the UK driving away pharmaceutical companies?

Jun 14, 20237 min read

NICE Scientific Advice – an updated process from 1st December 2022

NICE updated the process for providing scientific advice on December 2022, We describe these changes.

Dec 5, 20221 min read

Germany mandates real-world data collection for gene therapy Zolgensma

Germany’s HTA body is telling Novartis exactly what post-approval efficacy data it needs to see for SMA therapy Zolgensma.

Mar 22, 20213 min read

UK to provide upfront payment for new antibiotics via worldfirst ‘Netflix style’ scheme

Governments are starting to incentivise development of new antibiotics, by offering attractive funding propositions, as seen in the UK.

Nov 24, 20206 min read

Gene therapy: Can HTA capture the value of a potential cure?

Decades of research have resulted in several gene therapies successfully reaching the clinic and continued strong growth in the global...

Jul 9, 20206 min read